Netherlands: Mackison made CEO at Vico Therapeutics

Micah Mackison, CEO, VICO Therapeutics

Vico Therapeutics, a neurology-focused genetic medicine company, has appointed Micah Mackison as CEO. Mackison brings significant biotechnology and pharmaceutical leadership experience to Vico. He joins from Locanabio, an RNA-targeted gene therapy company, where he was chief business officer and executive VP of Strategy and Corporate Development. At Locanabio, Mackison was instrumental in setting strategy and raising capital….

You must be a HMI Subscriber to view this content.

Subscribe Now »